Clinical Trial Update: A Study of Omega-3 as a Treatment for Major Depression [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating omega-3 fatty acids as a treatment for major depressive disorder and persistent depressive disorder; current trial status is u…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Persistent Depressive Disorder

Drugs mentioned

• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: The University of New South Wales | Conditions: Major Depression, Dysthymia | Phase 2 | Status: UNKNOWN